Oglesby AK - Search Results

1

Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study.

Mills AM, Brunet L, Fusco JS, Wohlfeiler MB, Garris CP, Oglesby AK, Mrus JM, Lackey PC, Fusco GP. Mills AM, et al. Among authors: oglesby ak. Infect Dis Ther. 2020 Mar;9(1):41-52. doi: 10.1007/s40121-019-00274-5. Epub 2019 Nov 7. Infect Dis Ther. 2020. PMID: 31701370 Free PMC article.

2

Virologic Outcomes Among People Living With Human Immunodeficiency Virus With High Pretherapy Viral Load Burden Initiating on Common Core Agents.

Mills AM, Schulman KL, Fusco JS, Wohlfeiler MB, Priest JL, Oglesby A, Brunet L, Lackey PC, Fusco GP. Mills AM, et al. Open Forum Infect Dis. 2021 Jul 9;8(8):ofab363. doi: 10.1093/ofid/ofab363. eCollection 2021 Aug. Open Forum Infect Dis. 2021. PMID: 34381843 Free PMC article.

3

Real-World Experience with Dolutegravir-Based Two-Drug Regimens.

Ward D, Ramgopal M, Riedel DJ, Garris C, Dhir S, Waller J, Roberts J, Mycock K, Oglesby A, Collins B, Dominguez M, Pike J, Mrus J. Ward D, et al. AIDS Res Treat. 2020 Jul 7;2020:5923256. doi: 10.1155/2020/5923256. eCollection 2020. AIDS Res Treat. 2020. PMID: 32724674 Free PMC article.

4

Retrospective analysis of adherence to HIV treatment and healthcare utilization in a commercially insured population.

Priest J, Bhak RH, Dersarkissian M, Oglesby A, Kunzweiler C, Fuqua E, Park S, Duh MS, Garris C. Priest J, et al. J Med Econ. 2021 Jan-Dec;24(1):1204-1211. doi: 10.1080/13696998.2021.1995868. J Med Econ. 2021. PMID: 34665994 Free article.

5

Prospective Validation of the Lupus Impact Tracker: A Patient-Completed Tool for Clinical Practice to Evaluate the Impact of Systemic Lupus Erythematosus.

Jolly M, Kosinski M, Garris CP, Oglesby AK. Jolly M, et al. Among authors: oglesby ak. Arthritis Rheumatol. 2016 Jun;68(6):1422-31. doi: 10.1002/art.39601. Arthritis Rheumatol. 2016. PMID: 26814452

6

Impact of systemic lupus erythematosus on burden of illness and work productivity in the United States.

Garris C, Oglesby A, Sulcs E, Lee M. Garris C, et al. Lupus. 2013 Sep;22(10):1077-86. doi: 10.1177/0961203313498795. Epub 2013 Aug 6. Lupus. 2013. PMID: 23920376

7

Cost-effectiveness and budget impact of dolutegravir/lamivudine for treatment of human immunodeficiency virus (HIV-1) infection in the United States.

Butler K, Anderson SJ, Hayward O, Jacob I, Punekar YS, Evitt LA, Oglesby A. Butler K, et al. J Manag Care Spec Pharm. 2021 Jul;27(7):891-903. doi: 10.18553/jmcp.2021.27.7.891. J Manag Care Spec Pharm. 2021. PMID: 34185564 Free PMC article.

8

Benchmarking HIV Quality Measures Across US Payer Types.

Priest JL, Irwin DE, Evans KA, Oglesby AK, Brady BL. Priest JL, et al. Among authors: oglesby ak. Popul Health Manag. 2020 Apr;23(2):146-156. doi: 10.1089/pop.2019.0052. Epub 2019 Jul 15. Popul Health Manag. 2020. PMID: 31305206 Free PMC article.

9

Retrospective analysis of comorbidities and treatment burden among patients with HIV infection in a US Medicaid population.

DerSarkissian M, Bhak RH, Oglesby A, Priest J, Gao E, Macheca M, Sharperson C, Duh MS. DerSarkissian M, et al. Curr Med Res Opin. 2020 May;36(5):781-788. doi: 10.1080/03007995.2020.1716706. Epub 2020 Jan 24. Curr Med Res Opin. 2020. PMID: 31944138 Free article.

10

Clinical characteristics and treatment patterns among US patients with HIV.

Priest JL, Burton T, Blauer-Peterson C, Andrade K, Oglesby A. Priest JL, et al. Am J Manag Care. 2019 Dec;25(12):580-586. Am J Manag Care. 2019. PMID: 31860226 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters